Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
News
Job Board
CME/CE
Partners
Editorial
Subscribe
Alzheimer Disease
Latest News
Positive Phase 2b/3 Open-Label Extension Trial Results: Blarcamesine for Treatment of Early Alzheimer Disease
By Leah Kuntz
July 31st 2025
Anavex Life Sciences reveals significant cognitive and functional improvements in early Alzheimer disease patients using blarcamesine, highlighting its potential as a long-term treatment.
